Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS vaccine trials

Journal of the Medical Association of Thailand

Volumn 86, Issue 4, 2003, Pages 299-307

  Maek A Nantawat, Wirach ^a   Phonrat, Benjaluck ^a   Naksrisook, Supa ^a   Thantamnu, Narumon ^a   Pitisuttithum, Punnee ^a   Bussaratid, Valai ^a   Peonim, Wantanee ^a   Muanaum, Rungrapat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Counseling; HIV AIDS Vaccine Trial; Risk Assessment

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDUCATION; EVALUATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT ATTITUDE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SOCIAL ASPECT; THAILAND; VIRUS TRANSMISSION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATTITUDE; ETHNOLOGY; HIGH RISK BEHAVIOR; PATIENT PARTICIPATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS VACCINES; ATTITUDE; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; FEMALE; HUMANS; MALE; PATIENT PARTICIPATION; RISK-TAKING; THAILAND;

EID: 0038688347     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Liou A, Zimet GD, Fortenberry JD. Attitudes about human immunodeficiency virus immunization: The influence of health beliefs and vaccine characteristics. Sex Transm Dis 1998; 25: 76-81.
2. Jenkins RA, Temoshok LR, Virochsiri K. Incentives and disincentives to participate in prophylactic HIV vaccine research. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 36-42.
3. McKirnan DJ, Ostrow DG, Hope B. Sex, drugs and escape: A psychological model of HIV-risk sexual behaviors. AIDS Care 1996; 8: 655-9.
4. Chesney MA, Lurie P, Coates TJ. Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 30-5.
5. Meyers K, Metzger DS, Naraline H, Woody GE, McLellan AT. HIV vaccine trials: Will intravenous drug users enroll? Am J Public Health 1994; 84: 761-6.
6. Pinching AJ. Live attenuated vaccine trials in medically informed volunteers: A special care? J Med Ethics 2000; 26: 44-6.
7. Esparza J. Development of WHO-Sponsored sites for HIV vaccine evaluation. AIDS Res Hum Retroviruses 1993; 9: S133-4.
8. Kunasol P. International HIV/AIDS vaccine trials: Expectations of host countries. AIDS Res Hum Retroviruses 1993; 9: S135-6.
9. Phanuphak P, Teeratakulpixarn S, Sarangbin S, et al. International clinical trials of HIV vaccines: I Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pac J Allergy Immunol 1997; 15: 41-8.
10. Gagron MP, Godin G. Young adults and HIV vaccine: Determinants of the intention of getting immunized. Can J Public Health 2000; 91: 432-4.
11. Thapinta D, Jenkins RA, Celentano DD, et al. Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20: 308-14.
12. Allen M, Israel H, Rybczyk K, et al. Trial-related discrimination in HIV vaccine clinical trials. AIDS Res Hum Retroviruses 2001; 17: 667-74.
13. Strauss RP, Sengupta S, Kegeles S, et al. Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three US communities. J Acquir Immune Defic Syndr 2001; 26: 63-71.
14. Liau A, Zimet GD. Undergraduates' perception of HIV immunization: Attitudes and behaviours as determining factors. Int J STD AIDS 2000; 11: 445-50.